A PYMNTS Company

E.U.: Highest court backs more than 50M euro fine for AstraZeneca

By  |  December 6, 2012

The European Court of Justice, the European Union’s highest court, backed a fine issued to AstraZeneca after the pharmaceutical company was found to have hampered competition by blocking rivals from its ulcer drug Losec and selling it for less money. The fine is a validation of the General Court’s, Europe’s second-highest court, 2010 decision to support the European Commission’s finding that AstraZeneca had breached competition law, but is also supportive of of the General Court’s decision to lower the fine originally administered by the Commission of €60 million to €52.5 million.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Fox Business

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.